From: Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades
Indications | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Mean (by indication) | SD (by indication) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CARD | 3.7 | 2.5 | 1.9 | 2.4 | 1.4 | 1.3 | 1.4 | 1.3 | 1.3 | 2.0 | 1.6 | 1.5 | 1.3 | 1.6 | 1.9 | 1.0 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.8 | 0.6 |
DERM | 0.6 | 2.8 | 2.0 | 2.0 | 1.6 | 1.2 | 1.6 | 1.6 | 0.9 | 1.0 | 2.8 | 1.4 | 2.6 | 1.2 | 1.7 | 1.2 | 1.5 | 2.3 | 2.4 | 2.4 | 2.1 | 1.8 | 0.6 |
HAEM | 4.4 | 3.6 | 2.5 | 2.8 | 1.7 | 1.1 | 1.7 | 2.3 | 2.0 | 2.2 | 3.4 | 1.6 | 1.7 | 3.5 | 3.0 | 0.9 | 1.4 | 2.3 | 2.2 | 2.1 | 2.7 | 2.3 | 0.9 |
HORM | 8.0 | 2.6 | 4.7 | 3.0 | 1.5 | 1.2 | 1.2 | 1.1 | 0.9 | 0.7 | 0.7 | 1.1 | 3.4 | 0.7 | 1.6 | 1.2 | 2.1 | 1.9 | |||||
INFEC | 3.5 | 3.1 | 2.8 | 3.0 | 2.5 | 2.1 | 1.7 | 1.8 | 1.8 | 1.7 | 1.6 | 1.9 | 1.6 | 1.8 | 1.5 | 1.9 | 2.0 | 2.0 | 1.5 | 2.0 | 2.1 | 2.1 | 0.5 |
META | 2.4 | 2.1 | 1.7 | 1.4 | 1.7 | 1.6 | 1.5 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.5 | 1.2 | 1.8 | 1.9 | 1.5 | 1.8 | 2.1 | 2.1 | 1.9 | 1.6 | 0.3 |
MUSCO | 2.1 | 4.1 | 3.1 | 1.2 | 1.8 | 2.0 | 1.6 | 1.8 | 2.9 | 1.9 | 2.4 | 1.6 | 2.4 | 3.0 | 2.6 | 2.2 | 2.2 | 2.7 | 1.8 | 3.7 | 2.0 | 2.3 | 0.7 |
NEURO | 3.4 | 2.8 | 2.3 | 2.0 | 1.7 | 1.7 | 1.9 | 1.4 | 1.6 | 1.6 | 1.6 | 2.1 | 1.7 | 1.8 | 1.8 | 2.0 | 2.1 | 2.9 | 2.6 | 2.0 | 2.5 | 2.1 | 0.5 |
ONCIM | 7.2 | 3.9 | 3.9 | 3.5 | 3.5 | 3.9 | 4.1 | 3.4 | 3.7 | 3.6 | 3.3 | 3.2 | 3.7 | 3.5 | 3.7 | 4.1 | 3.6 | 3.9 | 3.8 | 4.3 | 4.3 | 3.9 | 0.8 |
PARA | |||||||||||||||||||||||
RESP | 3.4 | 2.2 | 1.4 | 1.7 | 1.6 | 1.5 | 1.6 | 0.9 | 0.7 | 1.2 | 0.9 | 1.1 | 1.4 | 1.3 | 1.4 | 1.3 | 1.3 | 1.4 | 1.3 | 2.0 | 1.5 | 1.5 | 0.5 |
SENS | 0.3 | 0.8 | 0.7 | 1.0 | 1.0 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 0.8 | 1.4 | 0.8 | 1.3 | 1.2 | 2.5 | 0.9 | 0.6 | 1.1 | 2.7 | 1.6 | 1.1 | 0.6 |
URO | 2.8 | 4.5 | 2.9 | 1.7 | 1.9 | 2.4 | 1.8 | 1.6 | 1.7 | 2.0 | 1.2 | 1.7 | 1.5 | 1.9 | 2.2 | 1.2 | 1.8 | 2.1 | 0.8 | 1.4 | 2.4 | 2.0 | 0.7 |
VAR | 2.3 | 0.9 | 1.9 | 1.6 | 2.6 | 1.7 | 1.8 | 0.7 | 0.8 | 0.4 | 2.0 | 2.7 | 0.9 | 0.7 | 0.8 | 1.4 | 2.0 | 1.8 | 1.2 | 1.2 | 1.3 | 1.5 | 0.6 |
Mean (by year) | 3.4 | 2.8 | 2.3 | 2.2 | 2.0 | 1.7 | 1.7 | 1.5 | 1.6 | 1.6 | 1.8 | 1.8 | 1.7 | 1.8 | 2.1 | 1.7 | 1.8 | 2.1 | 1.9 | 2.3 | 2.1 | ||
SD (by year) | 2.1 | 1.1 | 0.8 | 1.0 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 | 0.8 | 0.9 | 0.6 | 0.8 | 0.9 | 0.8 | 0.9 | 0.6 | 0.8 | 0.8 | 0.9 | 0.8 |